In last trading session, Windtree Therapeutics Inc (NASDAQ:WINT) saw 0.83 million shares changing hands with its beta currently measuring 0.53. Company’s recent per share price level of $3.29 trading at -$0.39 or -10.60% at ring of the bell on the day assigns it a market valuation of $1.68M. That closing price of WINT’s stock is at a discount of -813.68% from its 52-week high price of $30.06 and is indicating a premium of 12.16% from its 52-week low price of $2.89. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.15 million shares which gives us an average trading volume of 28.43K if we extend that period to 3-months.
For Windtree Therapeutics Inc (WINT), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 3.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Windtree Therapeutics Inc (NASDAQ:WINT) trade information
Upright in the red during last session for losing -10.60%, in the last five days WINT remained trading in the red while hitting it’s week-highest on Thursday, 07/25/24 when the stock touched $3.29 price level, adding 15.64% to its value on the day. Windtree Therapeutics Inc’s shares saw a change of -74.58% in year-to-date performance and have moved -10.35% in past 5-day. Windtree Therapeutics Inc (NASDAQ:WINT) showed a performance of 0.30% in past 30-days. Number of shares sold short was 47093.0 shares which calculate 1.64 days to cover the short interests.
Windtree Therapeutics Inc (WINT) estimates and forecasts
Statistics highlight that Windtree Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -60.27% of value to its shares in past 6 months, showing an annual growth rate of 97.47% while that of industry is 15.20. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 66.05% during past 5 years.
WINT Dividends
Windtree Therapeutics Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders
Insiders are in possession of 4.01% of company’s total shares while institution are holding 9.21 percent of that, with stock having share float percentage of 9.60%. Investors also watch the number of corporate investors in a company very closely, which is 9.21% institutions for Windtree Therapeutics Inc that are currently holding shares of the company.